new glp-1 drug How medications are transforming diabetes and weight loss treatment New research is taking a

J.ColvinM

Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein

These changes increase the risk of gastroparesis and bowel blockage [12]

Mast Cell Activation Syndrome (MCAS) is when mast cells become overly responsive and easily triggered and therefore, release a lot of histamine

Leading players compete through product innovation, expanding clinical indications, superior efficacy, strategic manufacturing investments, and robust commercialization capabilities

Nonetheless, investigators from the Canadian Network for Observational Drug Effect Studies (CNODES) reported contradictory results